Resistance of naive mice to murine hepatitis virus strain 3 requires development of a Th1, but not a Th2, response, whereas pre-existing antibody partially protects against primary infection

Advances in Experimental Medicine and Biology

Volumn 440, Issue , 1998, Pages 415-423

  Liu, M F ^a   Ning, Q ^a   Pope, M ^a   Mosmann, T ^b   Leibowitz, J ^c   Ding, J W ^a   Fung, L S ^a   Rotstein, O ^a   Gorczynski, R ^a   Levy, G A ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

^c TEXAS A AND M UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; INTERLEUKIN 1BETA; LYMPHOKINE; MONOCLONAL ANTIBODY; PROCOAGULANT; RIBAVIRIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HELPER CELL; IMMUNIZATION; LIVER FAILURE; MACROPHAGE; MOUSE; MURINE HEPATITIS CORONAVIRUS; NONHUMAN; PRIORITY JOURNAL; VIRUS HEPATITIS; VIRUS REPLICATION; VIRUS RESISTANCE;

ANIMALIA; CORONAVIRUS; MURINAE; MURINE HEPATITIS VIRUS; MURINE HEPATITIS VIRUS STRAIN 3;

EID: 0031750725     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-5331-1_52     Document Type: Article

References (18)

1. Belosevic, M., D. S. Finbloom, Pl H. Van der Meide, M. V. Slayter, and C. Nacy., 1989, Administration of monoclonal anti-IFN-gamma antibodies in vivo abrogates natural resistance of C3H/HeN mice to infection with Leishmania major, J. Immunol. 143: 266-274.
2. Chatelain, R., K. Varkila, and R. L. Coffman., 1992, IL-4 induces a Th2 response in Leishmania major-infected mice, J. Immunol. 148: 1182-1187.
3. Chung, S., R. Gorczynski, B. Cruz, R. Fingerote, E. Skamene, S. Perlman, J. L. Leibowitz, L. S. Fung, M. Flowers, and G. A. Levy., 1994, A Th1 helper cell line (3E9.1) from resistant A/J mice inhibits induction of macrophage procoagulatn activity (PCA) in vitro and protects against MHV-3 mortality in vivo, Immunol. 83: 353-361.
4. Chung, S., S. Sinclair, J. Leibowitz, E. Skamene, L. S. Fung, and G. Levy., 1991, Cellular and metabolic requirements for induction of macrophage procoagulant activity by murine hepatitis virus strain 3 in vitro, J. Immunol. 146: 271-278.
5. Dindzans, V. J., B. Zimmerman, A. Sherker, and G. A. Levy., 1987, Susceptibility to mouse hepatitis virus strain 3 in Balb/cJ mice: failure of immune cell proliferation and interleukin 2 production, Adv. Exp. Med. Biol. 218: 411-420.
6. Dupuy, J. M., E. Levy-Leblond, and C. Le Prevost., 1975, Immunopathology of mouse hepatitis virus type 3 infection. II. Effect of immunosuppression in resistant mice, J. Immunol. 114:226-230.
7. Fiorentino, D. F., A. Zlotnik, P. Vieira, T. R. Mosmann, M. Howard, K. W. Moore, and A. O'Garra., 1991, IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells, J. Immunol. 146:3444-3451.
8. Idwell, R. W., J. H. Huffman, N. Campbell, L. B. Allen., 1977, Effect of ribavirin on viral hepatitis in laboratory animal,. Annals of the New York Academy of Science. 284: 239-246.
9. Korner, H., A. Schliephake, J. Winter, F. Zimprich, H. Lassmann, J. Sedgwick, S. Siddell, and H. Wege., 1991, Nucleocapsid or spike protein-specific CD4+ T lymphocytes protect against coronavirus-induced encephalomyelitis in the absence of CD8+ cells., J. Immunol. 147: 2317-2323.
10. Lamontagne, L., and P. Jolicoeur., 1991, Mouse hepatitis virus 3-thymic cell intreactions correlating with viral pathogenecity, J. Immunol. 146: 3152-3159.
11. Levy, G. A., J. L. Leibowitz, and T.S. Edgington., 1981, Induction of monocyte rocagulant activity by murine hepatitis virus type 3 parallels disease susceptibility im mice, J. Ecp. Med. 154: 1150-1163.
12. Levy-Leblond, E., and J. M. Dupuy., 1977, Neonatal susceptibility to MHV-3 infection in mice. I. Transfer of resistance, J. Immunol. 118: 1219-1223.
13. Li, C., L. S. Fung, A. Crow, N. Myers-Mason, J. L. Leibowitz, E. Cole, and G. A. Levy., 1992, Monoclonal anti-prothrombinase (3D4.3) prevents mortality from murine hepatitis virus infection (MHV-3), J. Exp. Med. 1763: 689-697.
14. Mosmann, T. R., and R. L. Coffman., 1989, Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties, Annu. Rev. Immunol. 7: 145-214.
15. Parr, R., J. L. Leibowitz, L. S. Fung, S. J. Reneker, N. Myers-Mason, and G. A. Levy., 1995, The association of mouse fibrinogen-like protein (Musfiblp) with murine hepatitis virus induced prothrombinase activity, J. Virol. 69: 5033-5038.
16. Pope, M., O. Roststein, E. Cole, S. Sinclair, R. Parr, B. Cruz, R. Fingerote, S. Chung, R. Gorczynski, L. Fung, J. Leibowitz, Y. S. Rao, and G. Levy. 1995. Pattern of disease after murine hepatitis virus strain 3 infection correlates with macrophage activation and not viral replication, J. Virol. 69: 5252-5260.
17. Romani, L., A. Mencacci, U. Grohmann, S. Mocci, P. Mosci, P. Puccetti, and F. Bistoni., 1992, Neutralizing antibody to interleukin 4 inducess systemic protection and T helper type 1-associated immunity in murine candidiasis, J. Exp. Med. 176: 19-25.
18. Sypek, J. P., C. L. Chung, S. H. Mayeor, J. M. Subramanyam, S. J. Goldman, D. S. Sieburth, S. F. Wolf, and R. G. Schaub., 1993, Resolution of cutaneous leishmaniasis:interleukin-12 initiates a protective T helper type 1 immune response, J. Exp. Med. 177: 1797-1802